DHA new products are on the market!Xinhua Pharmaceutical seized the market of more than 5 billion

Mondo Finance Updated on 2024-01-19

On December 1, Xinhua brand fish oil DHA gel candy was put on sale on the official Tmall Fuya'an of Jingdong Fuya'an, which is a new product created by Xinhua Pharmaceutical around "brain health" and "puzzle" after the three fish oil products of "Jinzebai", "Jinbaiping" and "Jinruishou" series have achieved phased results.

The DHA market has great development potential, and Xinhua Pharmaceutical is full of advantages

DHA (docosahexaenoic acid), commonly known as "brain**", is a polyunsaturated fatty acid that is very important for the human body. DHA is a major element in the growth and maintenance of nervous system cells, and is an important component of the brain and retina, with up to 20% content in the human cerebral cortex and about 50% in the retina.

In recent years, studies have found that DHA has an important physiological effect on the growth and development of infants and young children, and can promote the intellectual and visual development of fetuses, infants and young children. In addition to infants and young children, DHA plays an important role in children, pregnant women, the elderly, etc., and many countries around the world (including China) have approved DHA as a nutritional enhancer.

Benefiting from the increasing demand for DHA in the fields of health food, infant formula, health care products, and pharmaceuticals, the global DHA market is growing rapidly. According to the research data of China Research Network, the global DHA market size will exceed 5 billion US dollars in 2022, of which more than 90% is fish oil DHA.

Deep-sea fish oil is one of the main ways to extract DHA. As early as 2013, Xinhua Pharmaceutical began the R&D layout in the field of fish oil, relying on strong R&D capabilities and technical support, Xinhua Pharmaceutical has successfully conquered the key technology of high-purity pharmaceutical fish oil, and the fish oil separation and purification technology has reached the international advanced level. It is with the endorsement of the above strong technical capabilities, Xinhua Pharmaceutical currently has the ability to produce a variety of high-end fish oil products, on the basis of which it has developed high-purity EPA series, high-purity DHA series and high-purity mixed series products, and the raw materials have been exported to the United States, Europe, Japan and other countries and regions.

It is worth mentioning that Xinhua Pharmaceutical's fish oil raw materials are selected from a single anchovy from Peruvian fishery, one of the world's four major fisheries, and the raw materials are comprehensively tested by international authoritative testing institutions for organic pollutants, pesticide residues, heavy metals, nuclear radiation and other items of general concern to consumers before entering the factory, so as to ensure the purity of the quality of the source.

In the category of "high-purity EPA fish oil", Xinhua Pharmaceutical's "gold" series of three products have achieved phased results, and now the company is aiming at high-purity DHA fish oil raw materials, focusing on the health demands of the public such as "brain health" and "puzzle", creating the DHA product, and further improving the company's forward-looking layout in the field of fish oil.

The combination of DHA+PS double components makes it a good helper for brain health

The brain is the central nervous system of the human body. With the improvement of people's awareness of health care, brain health has become the focus of people's daily attention, and the brain health supplement market is expanding rapidly.

The main consumers of brain health supplements are the elderly and students. Affected by age, the elderly are prone to Alzheimer's disease, migraine, Parkinson's disease, insomnia and other neurological diseases, while students have high academic Xi pressure and high frequency of brain use, and there is also a greater demand for brain health products.

According to Grand View Research market data, the market size of brain health supplements in 2021 was 76$800 million, which is expected to reach $157$400 million.

Most brain health products on the market today contain phosphatidylserine (PS), an important membrane phospholipid found in bacterial, yeast, plant, and mammalian cells, which is an important component of brain nerve cells and has shown potential in many aspects such as stress and memory-related problems, attention disorders, and age-related cognitive decline.

Xinhua Pharmaceutical's new product, fish oil DHA gel candy, consists of 300mgDHA + 20mgps, which can improve Alzheimer's disease in the elderly, improve memory and cognitive ability, anti-depression, anti-depression, auxiliary activation enzymes, etc., suitable for the elderly and students who often use the brain and have the need to improve memory. (Wang Yuehai, correspondent, Hu Yanhua, Yuan Xinghui).

Editor: Li Tao.

News Mailbox sdchinanewszb@163com

Related Pages